8 October 2019
Nobel Prize for discoveries of how cells sense and adapt to oxygen availability
"Oxygen reduction FirePASS technology has been actually born from the concept of Hypoxic Training introduced by our Hypoxico/FirePASS Group over 20 years ago."
Gary Kotliar, President of FirePASS Corporation
At that time I have disclosed in my US Patent Nr. 5.799,625 filed 21 July 1995 the following: “
"Hypoxic training activates the immune system and protective forces of the organism, and is used for medical, health and fitness purposes. Hypoxic training is a drug-free alternative for treatment and prevention of cardiopulmonary, gastrointestinal, gynecological, skin and ocular diseases, as well as various types of allergy, neurological disturbances, and other diseases. Hypoxic Training is also successfully used for increasing strength, endurance, vitality and resistance to various diseases of healthy people and athletes.”
A few years after that, I have discovered the Phenomena of the “Ignition Prevention in the Breathable Hypoxic Atmosphere”, which lead to creating of a totally new industry that employs Oxygen Reduction Systems for fire prevention. Now FirePASS became the safest alternative to the Nitrogen Injection systems introduced by the competition trying to circumvent my patents.
Finally three scientists have confirmed my vision and got the Nobel Price for this! My honest congratulation! Read here:
BREAKING NEWS: The 2019 Nobel Prize in Physiology or Medicine has been awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.”